Zhitong Finance App News, Zhongyuan Xiehe (600645.SH) issued an announcement. On September 15, 2026, the company received the “Decision on Issuing Warning Letter Measures against Zhongyuan Xiehe Cytogenetic Engineering Co., Ltd., Gong Hongjia, WANG HONGQI (Wang Hongqi), and Chen Yiqing” issued by the Tianjin Regulatory Bureau of the China Securities Regulatory Commission. After investigation, the company announced in July 2025 that it signed a real estate leasing contract with the related party Shanghai Yanli Biotechnology Co., Ltd. (hereinafter referred to as Shanghai Yanli) to rent real estate in Shanghai to establish an East China headquarters and coordinate resource allocation. The company's strategic plan for the establishment of the East China headquarters was not sufficiently verified, the basis was insufficient, and the rationality and necessity of the lease was insufficient. The information disclosed above on transactions relating to the leasing of Shanghai Yanli Real Estate was untrue and inaccurate, in violation of the provisions of Article 3 (1) of the “Administrative Measures on Information Disclosure of Listed Companies” (Securities Regulatory Commission Order No. 226).
The company's chairman Gong Hongjia, general manager Wang Hongqi (Wang Hongqi), and Chen Yiqing, then secretary of the board of directors, failed to perform their duties faithfully and diligently, in violation of section 4 of the “Administrative Measures on Information Disclosure of Listed Companies” (Securities Regulatory Commission Order No. 226), and bear the main responsibility for the company's irregularities.
According to Article 53 of the “Administrative Measures on Information Disclosure of Listed Companies” (Securities Regulatory Commission Order No. 226), the Tianjin Regulatory Bureau decided to take supervisory and administrative measures to issue warning letters against companies and related personnel and record them in the securities and futures market integrity file.